Coupled with the increase in tau phosphorylation (Figure S3E), our in vitro model therefore recapitulates the key features of human AD and Tau35 mice and is thus a disease‐relevant tool in which to assess functional changes. The gene discussed is MAPT; the disease is Alzheimer disease.